
FDA Public Meeting: Rare Disease Day 2022
FDA will host a virtual public meeting on March 4, 2022 to join the global observance of Rare Disease Day. The theme for FDA’s Rare
FDA will host a virtual public meeting on March 4, 2022 to join the global observance of Rare Disease Day. The theme for FDA’s Rare
In CAC2’s June webinar, “Beyond the Signature: Demystifying Informed Consent in Childhood Cancer,” we brought together an extraordinary panel of experts, including a clinical ethicist,
In CAC2’s May webinar, “Fertility Hope for Childhood Cancer Survivors” our speakers explored fertility preservation and future family building options for childhood cancer patients and
If you weren’t able to join us for the “Know Before You Go” drop-in session for CAC2 Members it isn’t too late to catch up
In CAC2’s April pop-up webinar, “Patient Advocacy, Non-Profit Foundations, and the Changing Landscape of Pediatric Cancer Funding,” our special guest, Dr. Kimryn Rathmell, shared compelling
In CAC2’s April webinar, “The Role of AI from Diagnosis to Treatment for Childhood Cancer,” our speakers explored how Artificial Intelligence is being used in
In CAC2’s “Fit for Filing” webinar, our speakers explored designing and conducting academic or academic industry collaborative trials that produce data suitable for regulatory filing.
In conjunction with the European Medicines Agency (EMA), the FDA Oncology Center of Excellence (OCE) held a one-hour Conversations on Cancer public panel discussion on
Children who receive cisplatin as part of their cancer treatment are at risk for progressive and/or permanent hearing loss as a result of their treatment.
Blogged with permission and thanks by the ACCELERATE Fit for Filing Working Group The ACCELERATE PLATFORM’S Fit for Filing (FFF) group was formed in 2019 to explore